Loading...
•
Dec 31, 2025
Ultralife Q4 2025 Earnings Report
Ultralife reported higher quarterly revenue and improved adjusted EBITDA, but recorded a net loss due to a large intangible asset impairment charge.
Key Takeaways
Ultralife delivered revenue growth and stronger adjusted EBITDA in Q4 2025 driven by Battery & Energy Products demand, though results were impacted by a non-cash intangible asset impairment that led to a quarterly net loss.
Revenue increased to 48481000 from 43852000 in the prior year quarter.
Gross profit improved to 12056000 with gross margin reaching 24.9%.
Net loss was 7422000 primarily due to a 12200000 intangible asset impairment charge.
Adjusted EBITDA rose to 5675000 compared to 3903000 in the prior year period.
Revenue by Segment
Forward Guidance
Ultralife expects to enter 2026 with strong backlog and operational improvements aimed at delivering profitable growth and increasing cash flow.
Positive Outlook
- Backlog reached 110200000 exiting 2025 reflecting strong order flow.
- Operational realignment expected to improve manufacturing efficiency.
- Rising demand across several commercial and defense markets.
- Improved production capacity to ramp new products into higher volumes.
- Management expects opportunities for large multi-year programs.
Challenges Ahead
- Communications Systems revenue declined significantly due to order timing.
- Non-cash impairment charge significantly impacted profitability.
- Exposure to global economic uncertainty and inflation pressures.
- Dependence on government and defense spending cycles.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...